Virginia Retirement Systems’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $652K | Buy |
+2,700
| New | +$652K | ﹤0.01% | 696 |
|
|
2023
Q2 | – | Sell |
-10,857
| Closed | -$5.2M | – | 980 |
|
|
2023
Q1 | $5.2M | Sell |
10,857
-24,043
| -69% | -$11.5M | 0.05% | 237 |
|
|
2022
Q4 | $14.7M | Buy |
34,900
+4,600
| +15% | +$1.93M | 0.15% | 168 |
|
|
2022
Q3 | $12.6M | Buy |
+30,300
| New | +$12.6M | 0.14% | 170 |
|
|
2022
Q1 | $17.7M | Buy |
31,500
+17,600
| +127% | +$9.91M | 0.17% | 153 |
|
|
2021
Q4 | $10.5K | Sell |
13,900
-1,900
| -12% | -$1.44K | 0.07% | 223 |
|
|
2021
Q3 | $11.8M | Sell |
15,800
-100
| -0.6% | -$74.6K | 0.12% | 199 |
|
|
2021
Q2 | $10.2M | Sell |
15,900
-1,800
| -10% | -$1.16M | 0.1% | 221 |
|
|
2021
Q1 | $10.1M | Buy |
17,700
+1,600
| +10% | +$914K | 0.1% | 229 |
|
|
2020
Q4 | $9.39M | Buy |
16,100
+5,100
| +46% | +$2.97M | 0.1% | 226 |
|
|
2020
Q3 | $5.67M | Buy |
11,000
+600
| +6% | +$309K | 0.06% | 267 |
|
|
2020
Q2 | $4.7M | Buy |
10,400
+4,400
| +73% | +$1.99M | 0.06% | 295 |
|
|
2020
Q1 | $2.1M | Buy |
6,000
+4,200
| +233% | +$1.47M | 0.03% | 376 |
|
|
2019
Q4 | $666K | Sell |
1,800
-200
| -10% | -$74K | 0.01% | 849 |
|
|
2019
Q3 | $665K | Hold |
2,000
| – | – | 0.01% | 824 |
|
|
2019
Q2 | $625K | Hold |
2,000
| – | – | 0.01% | 852 |
|
|
2019
Q1 | $611K | Buy |
2,000
+500
| +33% | +$153K | 0.01% | 842 |
|
|
2018
Q4 | $348K | Buy |
1,500
+100
| +7% | +$23.2K | ﹤0.01% | 963 |
|
|
2018
Q3 | $438K | Sell |
1,400
-2,300
| -62% | -$720K | 0.01% | 931 |
|
|
2018
Q2 | $1.07M | Buy |
3,700
+100
| +3% | +$28.9K | 0.01% | 664 |
|
|
2018
Q1 | $900K | Buy |
3,600
+1,600
| +80% | +$400K | 0.01% | 681 |
|
|
2017
Q4 | $477K | Buy |
+2,000
| New | +$477K | 0.01% | 827 |
|
|
2015
Q4 | $790K | Buy |
5,700
+1,500
| +36% | +$208K | 0.01% | 621 |
|
|
2015
Q3 | $564K | Hold |
4,200
| – | – | 0.01% | 673 |
|
|
2015
Q2 | $633K | Buy |
+4,200
| New | +$633K | 0.01% | 669 |
|